County of Lamar v. Purdue Pharma L.P. et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:17-op-45162 |
| Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
| Cause | 28:1332 Diversity-Product Liability |
| Case Filed: | Dec 21, 2017 |
| Case in other court: | Texas Eastern, 4:17-cv-00814 |
| Last checked: Friday Nov 08, 2019 4:55 PM EST |
|
Defendant
Purdue Pharma L.P.
|
Represented By
|
|
Defendant
Johnson & Johnson
|
|
|
Defendant
Kroger Texas L.P.
|
|
|
Defendant
McKesson Corporation
|
Represented By
|
|
Defendant
Morris & Dickson Co., LLC
|
|
|
Defendant
Mylan Pharmaceuticals Inc.
|
|
|
Defendant
Ortho-Mcneil-Janssen Pharmaceuticals Inc.
|
|
|
Defendant
Par Pharmaceutical Companies, Inc.
|
|
|
Defendant
Par Pharmaceutical, Inc.
|
|
|
Defendant
Purdue Pharma Inc.
|
Represented By
|
|
Defendant
Janssen Pharmaceuticals Inc.
|
|
|
Defendant
Sandoz Inc.
|
|
|
Defendant
SpecGx LLC
|
|
|
Defendant
The Kroger Co.
|
|
|
Defendant
The Purdue Frederick Company
|
Represented By
|
|
Defendant
Wal-Mart Stores Texas, LLC
|
|
|
Defendant
Walgreen Co.
|
Represented By
|
|
Defendant
Walmart Inc.
|
|
|
Defendant
Watson Laboratories Inc.
|
Represented By
|
|
Defendant
Cardinal Health Inc.
|
Represented By
|
|
Defendant
Actavis LLC
|
Represented By
|
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
|
Defendant
Allergan Finance LLC
|
Represented By
|
|
Defendant
Allergan PLC
|
|
|
Defendant
AmerisourceBergen Corporation
|
Represented By
|
|
Defendant
AmerisourceBergen Drug Corporation
|
|
|
Defendant
Amneal Pharmaceuticals LLC
|
|
|
Defendant
CVS Health Corporation
|
|
|
Defendant
CVS Pharmacy, Inc.
|
|
|
Defendant
DOES 1 - 100, Inclusive
|
|
|
Defendant
Endo Health Solutions Inc.
|
|
|
Defendant
Endo Pharmaceutical, Inc.
|
|
|
Defendant
Hikma Pharmaceuticals USA Inc.
|
|
|
Defendant
Indivior Inc.
|
Represented By
|
|
Defendant
Janssen Pharmaceutica Inc.
|
|
|
Plaintiff
County of Lamar
|
Represented By
|
| TERMINATED PARTIES | |
|
Defendant
Knoll Pharmaceutical Company
Terminated: 03/23/2018
|
|
|
Defendant
Teva Pharmaceutical Industries Ltd.
Terminated: 04/11/2018
|
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
Terminated: 04/11/2018
|
Represented By
|
|
Defendant
AbbVie Inc.
Terminated: 03/23/2018
|
|
|
Defendant
Cephalon Inc.
Terminated: 04/11/2018
|
Represented By
|
|
Defendant
Insys Therapeutics, Inc.
Terminated: 03/24/2018
|
Represented By
|
| Docket last updated: 04/08/2019 4:37 PM EDT |
| Monday, November 20, 2017 | ||
| Case Assigned to District Judge Amos L. Mazzant, III. (rpc, ) [Transferred from txed on 12/21/2017.] | ||
| DEMAND for Trial by Jury by County of Lamar. (rpc, ) [Transferred from txed on 12/21/2017.] | ||
| In accordance with the provisions of 28 USC Section 636(c), you are hereby notified that a U.S. Magistrate Judge of this district court is available to conduct any or all proceedings in this case including a jury or non-jury trial and to order the entry of a final judgment. The form[LINK:Consent to Proceed Before Magistrate Judge] is available on our website. All signed consent forms, excluding pro se parties, should be filed electronically using the event Notice Regarding Consent to Proceed Before Magistrate Judge . (rpc, ) [Transferred from txed on 12/21/2017.] | ||
| 1 | 1
COMPLAINT AND JURY DEMAND against All Defendants ( Filing fee $ 400 receipt number 0540-6560672.), filed by County of Lamar.(Simon, Jeffrey) [Transferred from txed on 12/21/2017.]
|
|
|
Att: 1
Civil Cover Sheet
|
||
| Tuesday, November 21, 2017 | ||
| 2 | 2
NOTICE of Attorney Appearance by John F Walker on behalf of County of Lamar (Walker, John) [Transferred from txed on 12/21/2017.]
|
|
| 3 | 3
NOTICE of Attorney Appearance by Reid William Martin on behalf of County of Lamar (Martin, Reid) [Transferred from txed on 12/21/2017.]
|
|
| 4 | 4
NOTICE of Attorney Appearance by Amy M. Carter on behalf of County of Lamar (Carter, Amy) [Transferred from txed on 12/21/2017.]
|
|
| 5 | 5
SUMMONS Issued as to Abbvie Inc.. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 6 | 6
SUMMONS Issued as to Actavis LLC. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 7 | 7
SUMMONS Issued as to Actavis Pharma, Inc. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 8 | 8
SUMMONS Issued as to Allergan Finance LLC. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 9 | 9
SUMMONS Issued as to AmerisourceBergen Corporation. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 10 | 10
SUMMONS Issued as to Cardinal Health, Inc. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 11 | 11
SUMMONS Issued as to Cephalon, Inc. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 12 | 12
SUMMONS Issued as to Endo Health Solutions, Inc. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 13 | 13
SUMMONS Issued as to Endo Pharmaceutical, Inc. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 14 | 14
SUMMONS Issued as to Insys Therapeutics, Inc. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 15 | 15
SUMMONS Issued as to Janssen Pharmaceuticals, Inc. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 16 | 16
SUMMONS Issued as to Johnson & Johnson. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 17 | 17
SUMMONS Issued as to Knoll Pharmaceutical Company. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 18 | 18
SUMMONS Issued as to McKesson Corporation. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 19 | 19
SUMMONS Issued as to Purdue Pharma Inc. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 20 | 20
SUMMONS Issued as to Purdue Pharma L.P. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 21 | 21
SUMMONS Issued as to Teva Pharmaceuticals USA, Inc. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 22 | 22
SUMMONS Issued as to The Purdue Frederick Company. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 23 | 23
SUMMONS Issued as to Watson Laboratories, Inc. (rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| Wednesday, November 29, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for AmerisourceBergen Corporation to 1/17/2018. 30 Days Granted for Deadline Extension.( rpc, ) [Transferred from txed on 12/21/2017.] | ||
| 24 | 24
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re AmerisourceBergen Corporation.( Smith, Melissa) [Transferred from txed on 12/21/2017.]
|
|
| 25 | 25
***FILED IN ERROR. PLEASE IGNORE***. Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re AmerisourceBergen Corporation.( Smith, Melissa) Modified on 11/30/2017 (rpc, ). [Transferred from txed on 12/21/2017.]
|
|
| Thursday, November 30, 2017 | ||
| ***FILED IN ERROR. Document # 25, Defendant's Unopposed Second Application for Extension of Time to Answer Complaint. PLEASE IGNORE.*** (rpc, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for Allergan Finance LLC to 1/17/2018. 30 Days Granted for Deadline Extension.( rpc, ) [Transferred from txed on 12/21/2017.] | ||
| ***FILED IN ERROR. Document # 28, Defendant's Unopposed Second Application for Extension of Time to Answer Complaint. PLEASE IGNORE.*** (rpc, ) [Transferred from txed on 12/21/2017.] | ||
| 26 | 26
CORPORATE DISCLOSURE STATEMENT filed by AmerisourceBergen Corporation (Smith, Melissa) [Transferred from txed on 12/21/2017.]
|
|
| 27 | 27
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Allergan Finance LLC.( Hill, Jack) [Transferred from txed on 12/21/2017.]
|
|
| 28 | 28
***FILED IN ERROR. PLEASE IGNORE***. Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Allergan Finance LLC.( Hill, Jack) Modified on 11/30/2017 (rpc, ). [Transferred from txed on 12/21/2017.]
|
|
| Friday, December 01, 2017 | ||
| Defendants' Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for Purdue Pharma L.P., Purdue Pharma Inc., and The Purdue Frederick Company to 1/17/2018. 30 Days Granted for Deadline Extension.( rpc, ) [Transferred from txed on 12/21/2017.] | ||
| 29 | 29
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Purdue Pharma Inc..( Reed, Noelle) [Transferred from txed on 12/21/2017.]
|
|
| 30 | 30
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Purdue Pharma L.P..( Reed, Noelle) [Transferred from txed on 12/21/2017.]
|
|
| 31 | 31
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re The Purdue Frederick Company.( Reed, Noelle) [Transferred from txed on 12/21/2017.]
|
|
| 32 | 32
CORPORATE DISCLOSURE STATEMENT filed by Purdue Pharma Inc., Purdue Pharma L.P., The Purdue Frederick Company [Transferred from txed on 12/21/2017.]
|
|
| 33 | 33
***FILED IN ERROR. PLEASE IGNORE***. Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Purdue Pharma Inc..( Reed, Noelle) Modified on 12/4/2017 (rpc, ). [Transferred from txed on 12/21/2017.]
|
|
| 34 | 34
***FILED IN ERROR. PLEASE IGNORE***. Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Purdue Pharma L.P..( Reed, Noelle) Modified on 12/4/2017 (rpc, ). [Transferred from txed on 12/21/2017.]
|
|
| 35 | 35
***FILED IN ERROR. PLEASE IGNORE***. Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re The Purdue Frederick Company.( Reed, Noelle) Modified on 12/4/2017 (rpc, ). [Transferred from txed on 12/21/2017.]
|
|
| Monday, December 04, 2017 | ||
| ***FILED IN ERROR. Document # 33, Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Purdue Pharma Inc. PLEASE IGNORE.*** (rpc, ) [Transferred from txed on 12/21/2017.] | ||
| ***FILED IN ERROR. Document # 34, Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Purdue Pharma L.P. PLEASE IGNORE.*** (rpc, ) [Transferred from txed on 12/21/2017.] | ||
| ***FILED IN ERROR. Document # 35, Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re The Purdue Frederick Company. PLEASE IGNORE.*** (rpc, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for Cardinal Health, Inc. to 12/28/2017. 30 Days Granted for Deadline Extension.( rpc, ) [Transferred from txed on 12/21/2017.] | ||
| ***FILED IN ERROR. Document # 37, Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Cardinal Health, Inc. PLEASE IGNORE.*** (rpc, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed Amended First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for Cardinal Health, Inc. to 1/18/2018. 30 Days Granted for Deadline Extension.( rpc, ) [Transferred from txed on 12/21/2017.] | ||
| 36 | 36
***FILED IN ERROR. PER ATTORNEY, SEE 38 . PLEASE IGNORE***. Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Cardinal Health, Inc..( Geyer, Christopher) Modified on 12/4/2017 (rpc, ). [Transferred from txed on 12/21/2017.]
|
|
| 37 | 37
***FILED IN ERROR. PLEASE IGNORE***. Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Cardinal Health, Inc..( Geyer, Christopher) Modified on 12/4/2017 (rpc, ). [Transferred from txed on 12/21/2017.]
|
|
| 38 | 38
Defendant's Unopposed Amended First Application for Extension of Time to Answer Complaint re Cardinal Health, Inc..( Geyer, Christopher) [Transferred from txed on 12/21/2017.]
|
|
| Tuesday, December 12, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for Insys Therapeutics, Inc. to 1/17/2018. 30 Days Granted for Deadline Extension.( rpc, ) [Transferred from txed on 12/21/2017.] | ||
| 39 | 39
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re INSYS Therapeutics, Inc.(Sarokhanian, Nicholas) [Transferred from txed on 12/21/2017.]
|
|
| 40 | 40
CORPORATE DISCLOSURE STATEMENT filed by Insys Therapeutics, Inc. (Sarokhanian, Nicholas) [Transferred from txed on 12/21/2017.]
|
|
| 41 | 41
***FILED IN ERROR. PLEASE IGNORE*** Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re INSYS Therapeutics, Inc.(Sarokhanian, Nicholas) Modified on 12/12/2017 (rpc, ). [Transferred from txed on 12/21/2017.]
|
|
| Wednesday, December 13, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for McKesson Corporation to 1/17/2018. 30 Days Granted for Deadline Extension.( rpc, ) [Transferred from txed on 12/21/2017.] | ||
| 42 | 42
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re McKesson Corporation.( Scott, Robert) [Transferred from txed on 12/21/2017.]
|
|
| 43 | 43
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re McKesson Corporation.( Scott, Robert) [Transferred from txed on 12/21/2017.]
|
|
| 44 | 44
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Watson Laboratories, Inc..( Stanfield, Craig) [Transferred from txed on 12/21/2017.]
|
|
| 45 | 45
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Actavis Pharma, Inc..( Stanfield, Craig) [Transferred from txed on 12/21/2017.]
|
|
| 46 | 46
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Teva Pharmaceuticals USA, Inc..( Stanfield, Craig) [Transferred from txed on 12/21/2017.]
|
|
| 47 | 47
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Cephalon, Inc..( Stanfield, Craig) [Transferred from txed on 12/21/2017.]
|
|
| 48 | 48
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Actavis LLC.( Stanfield, Craig) [Transferred from txed on 12/21/2017.]
|
|
| 49 | 49
CORPORATE DISCLOSURE STATEMENT filed by Actavis LLC, Actavis Pharma, Inc., Watson Laboratories, Inc. identifying Corporate Parent Teva Pharmaceuticals Industries, Ltd. for Actavis LLC, Actavis Pharma, Inc., Watson Laboratories, Inc.. (Stanfield, Craig) [Transferred from txed on 12/21/2017.]
|
|
| 50 | 50
CORPORATE DISCLOSURE STATEMENT filed by Cephalon, Inc., Teva Pharmaceuticals USA, Inc. (Stanfield, Craig) [Transferred from txed on 12/21/2017.]
|
|
| Thursday, December 14, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for Teva Pharmaceuticals USA, Inc. to 1/17/2018; Watson Laboratories, Inc. to 1/17/2018; Actavis Pharma, Inc. to 1/17/2018; Cephalon, Inc. to 1/17/2018. 30 Days Granted for Deadline Extension.( cm, ) [Transferred from txed on 12/21/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for Actavis LLC to 1/18/2018. 30 Days Granted for Deadline Extension.( cm, ) [Transferred from txed on 12/21/2017.] | ||
| ***FILED IN ERROR. PLEASE IGNORE. *** Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for McKesson Corporation to 2/1/2018. 15 Days Granted for Deadline Extension.( cm, ) Modified on 12/14/2017 (cm, ). [Transferred from txed on 12/21/2017.] | ||
| ***GRANTED IN ERROR. Entry Granting McKesson Corporation's Second Application for Extension of Time to Answer Complaint. PLEASE IGNORE.*** (cm, ). [Transferred from txed on 12/21/2017.] | ||
| Friday, December 15, 2017 | ||
| 51 | 51
CONDITIONAL TRANSFER ORDER (CTO 1). On December 5, 2017, the Panel transferred 62 civil action(s) to the United States District Court for the Northern District of Ohio for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. § 1407. See _F.Supp.3d_ (J.P.M.L. 2017).(rpc, ) [Transferred from txed on 12/21/2017.]
|
|
| 52 | 52 Interdistrict transfer to the Northern District of Ohio. (rpc, ) [Transferred from txed on 12/21/2017.] | |
| Thursday, December 21, 2017 | ||
| 53 | 53
CASE TRANSFERRED IN from District of Texas Eastern. Case number 4:17-cv-00814. Original file, certified copy of transfer order and docket sheet received.
|
|